Antibodies targeting talaromyces marneffei mp1p protein and methods of use thereof
US-2024199726-A1 · Jun 20, 2024 · US
US10001489B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10001489-B2 |
| Application number | US-201314654731-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 19, 2013 |
| Priority date | Dec 20, 2012 |
| Publication date | Jun 19, 2018 |
| Grant date | Jun 19, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An affinity ligand peptide library of IgG constructed on the basis of Protein A affinity model and the application of a design method thereof. According to the Molecular Mechanics—Poisson-Boltzmann surface area (MM/PBSA) method and on the basis of the known human IgG-Protein A complex structure, the hot spots of Protein A that have high affinity for human IgG are obtained analytically, and a Protein A simplified affinity model is built thereof. An affinity peptide library of IgG is constructed including heptapeptide and octapeptide structural modes. On the basis of the peptide structural modes, the types of inserted amino acids that ‘X’ residues represent are further identified using amino acid location method. Then, molecular docking and molecular dynamics simulation methods are used to screen the candidate peptides successively. Finally, the affinity peptide ligands that can effectively purify IgG are identified using affinity chromatography.
Opening claim text (preview).
The invention claimed is: 1. A method for constructing a novel affinity ligand peptide library for binding immunoglobulin G on the basis of an affinity model of Protein A, comprising: adding a cysteine to a middle region of a peptide to obtain the following peptides: FYCHXXXE, FYXHCXXE, FYCHXXR, FYXHCXR, FYXCRXE, YFXCRXE, HXYFCXR, and HXYFCXK; wherein ‘X’ represents the common 19 amino acids except cysteine; and synthesizing one or more of the peptides. 2. The method of claim 1 , wherein, the constructing is on the basis of six Staphylococal Protein A hot spots: F132, Y133, H137, E143, R146, and K154. 3. The method of claim 1 , further comprising determining the kinds of amino acids ‘X’ in the peptides that are within the scope of the peptide library using an amino acid location method. 4. The method of claim 3 , wherein, a candidate peptide library is obtained and shown below: Peptide & Number of peptides Amino acids ‘X’ represents FYCHX 1 X 2 X 3 E X 1 : A, R, N, D, Q, E, H, I, L, K, M, number: 990 T, W, Y, V X 2 : A, Q, E, I, L, K X 3 : A, R, D, Q, E, L, K, M, P, S, T FYX 1 HCX 2 X 3 E X 1 : A, R, N, D, I, P, T, W, Y number: 594 X 2 : A, Q, E, I, L, K X 3 : A, R, D, Q, E, L, K, M, P, S, T FYCHX 1 X 2 R X 1 : N, D, Q, E, H, I, K, M, F, P, T, number: 112 W, Y, V X 2 : Q, E, H, I, K, M, F, W FYX 1 HCX 2 R X 1 : A, R, N, D, I, P, T, W, Y number: 72 X 2 : Q, E, H, I, K, M, F, W FYX 1 CRX 2 E X 1 : A, R, N, D, Q, E, G, H, I, L, K, number: 153 M, F, P, W, Y, V X 2 : N, D, Q, E, L, M, S, T, W YFX 1 CRX 2 E X 1 : N, D, E, H, I, L, K, M,P, S, T, number: 117 Y, V X 2 : N, D, Q, E, L, M, S, T, W HX 1 YFCX 2 R X 1 : A, R, N, D, I, P, T, W, Y number: 54 X 2 : Q, H, K, S, W, Y HX 1 YFCX 2 K X 1 : A, R, N, D, I, P, T, W, Y number: 81 X 2 : A, R, Q, H, K, F, W, Y, V. 5. The method of claim 4 , wherein the peptides in the candidate peptide library are screened by molecular docking, RMSD comparison, and rescreened by molecular dynamics simulation, obtaining peptide ligands possessing high affinity for human immunoglobulin G, which are SEQ ID NO: 1499, FYWHCLDE; SEQ ID NO: 1883, FYFCRWE; SEQ ID NO: 1309, FYIHCLPE; SEQ ID NO: 1576, FYYHCKKE; SEQ ID NO: 859, FYCHWALE; SEQ ID NO: 798, FYCHWQDE; SEQ ID NO: 757, FYCHTIDE; SEQ ID NO: 1073, FYRIICQRE; SEQ ID NO: 397, FYCHHKTE; SEQ ID NO: 606, FYCHLQKE; SEQ ID NO: 122, FYCHRKAE; SEQ ID NO: 147, FYCHNQDE; SEQ ID NO: 82, FYCHRQEE; and SEQ ID NO: 1133, FYNHCASE. 6. The method of claim 2 , further comprising determining the kinds of amino acids ‘X’ in the peptides that are within the scope of the peptide library using an amino acid location method. 7. The method of claim 6 , wherein, a candidate peptide library is obtained and shown below: Peptide & Number of peptides Amino acids ‘X’ represents FYCHX 1 X 2 X 3 E X 1 : A, R, N, D, Q, E, H, I, L, K, M, number: 990 T, W, Y, V X 2 : A, Q, E, I, L, K X 3 : A, R, D, Q, E, L, K, M, P, S, T FYX 1 HCX 2 X 3 E X 1 : A, R, N, D, I, P, T, W, Y number: 594 X 2 : A, Q, E, I, L, K X 3 : A, R, D, Q, E, L, K, M, P, S, T FYCHX 1 X 2 R X 1 : N, D, Q, E, H, I, K, M, F, P, T, number: 112 W, Y, V X 2 : Q, E, H, I, K, M, F, W FYX 1 HCX 2 R X 1 : A, R, N, D, I, P, T, W, Y number: 72 X 2 : Q, E, H, I, K, M, F, W FYX
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Immunoglobulins · CPC title
having 5 to 11 amino acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.